MedTrace Logo

Clinical Significance of circMETTL9 Gene in Traumatic Brain Injury

NCT05484921 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2022-08-05

No results posted yet for this study

Summary

Objective: The relevance of circMETTL9 to the degree of injury, disturbance of consciousness, cognitive function and prognosis in patients with moderate to severe traumatic brain injury (TBI) remains unknown. The purpose of this study was to investigate the effect of circMETTL9 on the degree of injury, disturbance of consciousness, cognitive function and prognosis after TBI.

Conditions

  • TBI (Traumatic Brain Injury)

Sponsors & Collaborators

  • Affiliated Hospital of Nantong University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-04
Primary Completion
2023-12-30
Completion
2023-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05484921 on ClinicalTrials.gov